BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 18632670)

  • 1. Heat shock transcription factor 1-activating compounds suppress polyglutamine-induced neurodegeneration through induction of multiple molecular chaperones.
    Fujikake N; Nagai Y; Popiel HA; Okamoto Y; Yamaguchi M; Toda T
    J Biol Chem; 2008 Sep; 283(38):26188-97. PubMed ID: 18632670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular therapy targeting protein misfolding and aggregation for the polyglutamine diseases].
    Nagai Y
    Rinsho Shinkeigaku; 2009 Nov; 49(11):913-6. PubMed ID: 20030247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein.
    Waza M; Adachi H; Katsuno M; Minamiyama M; Tanaka F; Doyu M; Sobue G
    J Mol Med (Berl); 2006 Aug; 84(8):635-46. PubMed ID: 16741751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of molecular chaperones as a therapeutic strategy for the polyglutamine diseases.
    Nagai Y; Fujikake N; Popiel HA; Wada K
    Curr Pharm Biotechnol; 2010 Feb; 11(2):188-97. PubMed ID: 20166962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular stress-inducing compounds increase osteoclast formation in a heat shock factor 1 protein-dependent manner.
    Chai RC; Kouspou MM; Lang BJ; Nguyen CH; van der Kraan AG; Vieusseux JL; Lim RC; Gillespie MT; Benjamin IJ; Quinn JM; Price JT
    J Biol Chem; 2014 May; 289(19):13602-14. PubMed ID: 24692538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of multiple heat shock proteins and neuroprotection in a primary culture model of familial amyotrophic lateral sclerosis.
    Batulan Z; Taylor DM; Aarons RJ; Minotti S; Doroudchi MM; Nalbantoglu J; Durham HD
    Neurobiol Dis; 2006 Nov; 24(2):213-25. PubMed ID: 16950627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of heat shock transcription factor 1 as a therapeutic target for small molecule intervention in neurodegenerative disease.
    Neef DW; Turski ML; Thiele DJ
    PLoS Biol; 2010 Jan; 8(1):e1000291. PubMed ID: 20098725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alleviating neurodegeneration by an anticancer agent: an Hsp90 inhibitor (17-AAG).
    Waza M; Adachi H; Katsuno M; Minamiyama M; Tanaka F; Sobue G
    Ann N Y Acad Sci; 2006 Nov; 1086():21-34. PubMed ID: 17185503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geldanamycin induces heat shock protein 70 and protects against MPTP-induced dopaminergic neurotoxicity in mice.
    Shen HY; He JC; Wang Y; Huang QY; Chen JF
    J Biol Chem; 2005 Dec; 280(48):39962-9. PubMed ID: 16210323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule inducers of heat-shock response reduce polyQ-mediated huntingtin aggregation. A possible therapeutic strategy.
    Herbst M; Wanker EE
    Neurodegener Dis; 2007; 4(2-3):254-60. PubMed ID: 17596719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing the role of Hsp90 in production of heat shock proteins in motor neurons reveals a suppressive effect of wild-type Hsf1.
    Taylor DM; Tradewell ML; Minotti S; Durham HD
    Cell Stress Chaperones; 2007; 12(2):151-62. PubMed ID: 17688194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin abrogates the geldanamycin-induced heat shock response.
    McCollum AK; Lukasiewicz KB; Teneyck CJ; Lingle WL; Toft DO; Erlichman C
    Mol Cancer Ther; 2008 Oct; 7(10):3256-64. PubMed ID: 18852129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol induces apoptosis in K562 (chronic myelogenous leukemia) cells by targeting a key survival protein, heat shock protein 70.
    Chakraborty PK; Mustafi SB; Ganguly S; Chatterjee M; Raha S
    Cancer Sci; 2008 Jun; 99(6):1109-16. PubMed ID: 18429957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring the induction of heat shock factor 1/heat shock protein 70 expression following 17-allylamino-demethoxygeldanamycin treatment by positron emission tomography and optical reporter gene imaging.
    Doubrovin M; Che JT; Serganova I; Moroz E; Solit DB; Ageyeva L; Kochetkova T; Pillarsetti N; Finn R; Rosen N; Blasberg RG
    Mol Imaging; 2012 Feb; 11(1):67-76. PubMed ID: 22418029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of polyglutamine protein toxicity by co-expression of a heat-shock protein 40 and a heat-shock protein 110.
    Kuo Y; Ren S; Lao U; Edgar BA; Wang T
    Cell Death Dis; 2013 Oct; 4(10):e833. PubMed ID: 24091676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of heat shock factor 1 plays a role in pyrrolidine dithiocarbamate-mediated expression of the co-chaperone BAG3.
    Song S; Kole S; Precht P; Pazin MJ; Bernier M
    Int J Biochem Cell Biol; 2010 Nov; 42(11):1856-63. PubMed ID: 20692357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intercellular chaperone transmission via exosomes contributes to maintenance of protein homeostasis at the organismal level.
    Takeuchi T; Suzuki M; Fujikake N; Popiel HA; Kikuchi H; Futaki S; Wada K; Nagai Y
    Proc Natl Acad Sci U S A; 2015 May; 112(19):E2497-506. PubMed ID: 25918398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p62 plays a protective role in the autophagic degradation of polyglutamine protein oligomers in polyglutamine disease model flies.
    Saitoh Y; Fujikake N; Okamoto Y; Popiel HA; Hatanaka Y; Ueyama M; Suzuki M; Gaumer S; Murata M; Wada K; Nagai Y
    J Biol Chem; 2015 Jan; 290(3):1442-53. PubMed ID: 25480790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible involvement of HSP90-HSF1 multichaperone complex in impairment of HSP72 induction in the failing heart following myocardial infarction in rats.
    Marunouchi T; Araki M; Murata M; Takagi N; Tanonaka K
    J Pharmacol Sci; 2013; 123(4):336-46. PubMed ID: 24285117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis.
    Dello Russo C; Polak PE; Mercado PR; Spagnolo A; Sharp A; Murphy P; Kamal A; Burrows FJ; Fritz LC; Feinstein DL
    J Neurochem; 2006 Dec; 99(5):1351-62. PubMed ID: 17064348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.